^
BIOMARKER:

BRAF wild-type

i
Other names: BRAF, B-raf proto-oncogene, B-raf proto-oncogene, Serine/threonine kinase, V-Raf murine sarcoma viral oncogene homolog B, Serine/threonine-protein kinase B-Raf, Proto-oncogene B-Raf, BRAF1, RAFB1, B-raf proto-oncogene Serine/threonine-protein kinase, Murine sarcoma viral (V-Raf) oncogene homolog B1, B-raf serine/threonine-protein, 94 KDa B-raf protein, B-RAF1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
BRAF wild-type
Cutaneous Melanoma
nivolumab + ipilimumab
Sensitive
:
A2
BRAF wild-type
Cutaneous Melanoma
pembrolizumab
Sensitive
:
A2
BRAF wild-type
Cutaneous Melanoma
nivolumab
Sensitive
:
A2
BRAF wild-type
Colon Cancer
cetuximab
Sensitive
:
A2
BRAF wild-type
Colon Cancer
panitumumab
Sensitive
:
A2
BRAF wild-type
Rectal Cancer
cetuximab
Sensitive
:
A2
BRAF wild-type
Rectal Cancer
panitumumab
Sensitive
:
A2
BRAF wild-type
Melanoma
nivolumab
Sensitive
:
B
BRAF wild-type
Colorectal Cancer
bevacizumab
Sensitive
:
B
BRAF wild-type
Melanoma
selumetinib
Sensitive
:
C2
BRAF wild-type
Melanoma
trametinib
Sensitive
:
C2
BRAF wild-type
Colorectal Cancer
cetuximab
Sensitive
:
C2
BRAF wild-type
Colorectal Cancer
anlotinib
Sensitive
:
C2
BRAF wild-type
Colorectal Cancer
panitumumab
Sensitive
:
C2
BRAF wild-type
Colorectal Cancer
CPGJ-602
Sensitive
:
C2
BRAF wild-type
Melanoma
pembrolizumab + trametinib
Sensitive
:
C3
BRAF wild-type
Melanoma
PD1 inhibitor
Sensitive
:
C3
BRAF wild-type
Melanoma
dacarbazine
Sensitive
:
C4